Flag of the European Union EU Clinical Trials Register Help

Clinical trials for H1N1 Influenza Virus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44358   clinical trials with a EudraCT protocol, of which   7384   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    171 result(s) found for: H1N1 Influenza Virus. Displaying page 5 of 9.
    « Previous 1  2  3  4  5  6  7  8  9  Next»
    EudraCT Number: 2007-002614-19 Sponsor Protocol Number: FluvalAB-H-YL2007 Start Date*: 2007-09-05
    Sponsor Name:Omninvest Ltd.
    Full Title: FluvalAB Seasonal Influenza Vaccine Serologic Clinical Trial for 2007-2008 Influenza Season
    Medical condition: Immunization of healthy people against influenza virus infections.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2007-000752-14 Sponsor Protocol Number: GRT82 Start Date*: 2011-04-19
    Sponsor Name:Sanofi Pasteur SA
    Full Title: Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)
    Medical condition: Vaccination of healthy subjects aged 18 to 60 years (i.e. to the day before the 61st birthday) or 61 years or above (from the day of the 61st birthday) on the day of inclusion with one dose of the ...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-002153-30 Sponsor Protocol Number: FluvalAB-H-YL2013 Start Date*: 2013-08-22
    Sponsor Name:Omninvest Ltd.
    Full Title: Tolerability and Immunogenicity Study of FLUVAL AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μgHA/strain/0.5 mL) for the Use in the Season 2013/2014 in Adults and Elderl...
    Medical condition: Immunization of healthy people against influenza virus infection
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004865 10059430 Influenza immunization LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-020312-12 Sponsor Protocol Number: 114294 Start Date*: 2010-09-16
    Sponsor Name:GlaxoSmithKline S.A.
    Full Title: Estudio fase IIa, observador-ciego, multinacional, multicéntrico, aleatorizado para evaluar la inmunogenicidad, seguridad y reactogenicidad de la vacuna antigripal tetravalente (QIV) adyuvada con d...
    Medical condition: Vacunación frente a la gripe A y B de niños sanos, de 6 a 35 meses de edad, que no hayan recibido ninguna vacunación frente a la gripe (estacional y pandémica).
    Disease: Version SOC Term Classification Code Term Level
    12.1 10022000 Influenza LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Prematurely Ended) FI (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-005107-24 Sponsor Protocol Number: V112_06 Start Date*: 2014-12-04
    Sponsor Name:Novartis Vaccines and Diagnostics
    Full Title: Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1) 2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
    Medical condition: Prophylaxis of A (H1N1) 2009 Pandemic Influenza
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2020-002785-13 Sponsor Protocol Number: V130_10 Start Date*: 2020-12-04
    Sponsor Name:Seqirus Inc.
    Full Title: A Phase 3, Randomized, Observer-Blind, Multicenter, Noninferiority Study to Evaluate Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine (QIVc) and a United State...
    Medical condition: Prophylaxis of Influenza Virus Infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10022000 Influenza PT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2004-002225-45 Sponsor Protocol Number: S206.3.009 Start Date*: 2004-12-22
    Sponsor Name:Solvay Pharmaceuticals B.V.
    Full Title: Randomized, endpoint-blind, parallel group study to demonstrate the serological non-inferiority of the virosomal influenza vaccine Invivac® to the conventional subunit influenza vaccine Influvac® a...
    Medical condition: Influenza vaccine
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) LT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-021073-36 Sponsor Protocol Number: 113314 Start Date*: 2010-09-17
    Sponsor Name:GlaxoSmithKline
    Full Title: Estudio fase III, doble ciego aleatorizado para evaluar la inmunogenicidad y seguridad de la vacuna antigripal tetravalente de GSK Biologicals GSK2282512A (FLU Q-QIV) comparada con la vacuna antigr...
    Medical condition: Gripe Estacional
    Disease: Version SOC Term Classification Code Term Level
    12.1 10022000 Influenza LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-018392-22 Sponsor Protocol Number: 114182 Start Date*: 2010-03-24
    Sponsor Name:GlaxoSmithKline S.A.
    Full Title: Estudio fase I, abierto, multicéntrico para evaluar la seguridad e inmunogenicidad de la vacuna antigripal estacional trivalente (GSK2186877A) adyuvada con varias dosis de AS03, administrada en niñ...
    Medical condition: Vacunación frente a la gripe A y B de niños sanos, de 6 a 35 meses, que no hayan recibido la vacunación antigripal con anterioridad.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10059430 Influenza immunization LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-001600-12 Sponsor Protocol Number: F/2004/2. Start Date*: 2004-09-20
    Sponsor Name:OMNINVEST Kft.
    Full Title: Fluval AB Vaccine Serologic Clinical Trial
    Medical condition: Immunization of healthy people against influenza virus infections.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2017-000952-24 Sponsor Protocol Number: Flu-shed Start Date*: 2017-05-17
    Sponsor Name:Public Health England
    Full Title: Assessment of viral shedding in children previously in receipt of multiple doses of live attenuated influenza vaccine (LAIV) compared to influenza vaccine-naïve controls
    Medical condition: N/A - the vaccine will be administered to children according to current DH Immunisation schedule for England.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10016794 Flu vaccination LLT
    Population Age: Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-003449-40 Sponsor Protocol Number: FABNovo-H-16 Start Date*: 2014-10-15
    Sponsor Name:Omninvest Ltd.
    Full Title: Immunogenicity and Tolerability Study of FLUVAL AB Novo Suspension for Injection (trivalent, seasonal influenza vaccine, active ingredient content: 6 μg HA/strain/0.5 ml) for Children and Adolescents
    Medical condition: Immunization of healthy children and adolescents against influenza virus infection
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004865 10059430 Influenza immunization LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-018371-18 Sponsor Protocol Number: V44_14S Start Date*: 2010-04-22
    Sponsor Name:Novartis Vaccines and Diagnostics GmbH
    Full Title: A Phase III, multicenter, uncontrolled, open-label study to evaluate safety and immunogenicity of Begrivac®, preservative free, inactivated split influenza vaccine, using the strain composition 201...
    Medical condition: no medical condition, healthy volunteers will be recruited into the clinical trial for annual approval of influenza vaccine with the new strain composition according WHO and EMEA recommendation and...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10022000 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002134-74 Sponsor Protocol Number: FLU-v004 Start Date*: 2016-07-27
    Sponsor Name:PepTcell Limited (trade name SEEK)
    Full Title: Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model
    Medical condition: Influenza virus
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10022000 Influenza PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-000789-39 Sponsor Protocol Number: 116663 Start Date*: 2012-06-28
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: A Phase III, open, non-randomized, multi-centre, single dose study to assess immunogenicity and safety of Fluarix/Influsplit SSW 2012/2013 injected intramuscularly in adults (18 to 60 years) and in...
    Medical condition: Immunization against Influenza of healthy adults
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10059430 Influenza immunization LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-019040-39 Sponsor Protocol Number: V78_08S Start Date*: 2010-04-28
    Sponsor Name:Novartis Vaccines and Diagnostics GmbH
    Full Title: A Phase III, multicenter, uncontrolled, open label study to evaluate safety and immunogenicity of FLUVIRIN® [Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur], Formulation 2010/2011, when ad...
    Medical condition: Prophylaxis of influenza
    Disease: Version SOC Term Classification Code Term Level
    12.1 10022000 Influenza LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-000963-28 Sponsor Protocol Number: V71P5S Start Date*: 2007-06-07
    Sponsor Name:NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
    Full Title: A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of AGRIPPAL S1 Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2007-2008, when Administer...
    Medical condition: Active influenza immunoprofilaxis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10059429 Influenza immunisation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-002158-30 Sponsor Protocol Number: FLUVAL AB-H-YL2011 Start Date*: 2011-07-20
    Sponsor Name:Omninvest Ltd.
    Full Title: Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μg HA/strain/0.5 mL) in Adults and Elderly Persons
    Medical condition: Immunization of healthy people against influenza virus infection.
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10059429 Influenza immunisation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-021034-63 Sponsor Protocol Number: 114269 Start Date*: 2010-09-23
    Sponsor Name:GlaxoSmithKline S.A.
    Full Title: Estudio fase III multicéntrico, multinacional, aleatorizado, parcialmente ciego, controlado para evaluar la inmunogenicidad, reactogenicidad y seguridad de la vacuna antigripal tetravalente de GSK ...
    Medical condition: Inmunización de adultos de 18 años o más frente a la gripe
    Disease: Version SOC Term Classification Code Term Level
    13 10022000 Influenza LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003331-44 Sponsor Protocol Number: CSLCT-NHF-05-11 Start Date*: 2005-09-30
    Sponsor Name:CSL Limited
    Full Title: A Randomized, Observer-Blind, Single-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Enzira 2005/2006 compared to Mutagrip 2005/2006 in Healthy 'Adults@ aged >18 to <60 year...
    Medical condition: prophylaxis of influenza
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Sep 05 21:04:20 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA